Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology – Evolution versus revolution. (September 2019)

• Record Type: Journal Article
• Authors: Burgdorf, T.; Piersma, A.H.; Landsiedel, R.; Clewell, R.; Kleinstreuer, N.; Oelgeschläger, M.; Desprez, B.; Kienhuis, A.; Bos, P.; de Vries, R.; de Wit, L.; Seidle, T.; Scheel, J.; Schönfelder, G.; van Benthem, J.; Vinggaard, A.M.; Eskes, C.; Ezendam, J.
• Is Part Of: Toxicology in vitro. Volume 59(2019)
• Page Start: 1
• Page End: 11
• Publication Date: 2019-09
• Subjects: Workshop -- Validation -- Evolution -- Revolution -- Relevance -- Case studies; AOP Adverse outcome pathway -- DA Defined Approach -- HTS High throughput screening -- IATA Integrated Approaches to Testing and Assessment -- KE Key event -- MAD Mutual Acceptance of Data -- OECD Organization for Economic Cooperation and Development -- REACH Registration, Evaluation, Authorisation and Restriction of Chemicals -- WoE weight-of-evidence; Toxicity testing -- In vitro -- Periodicals; Toxicology -- Periodicals; 615.9
• DOI: 10.1016/j.tiv.2019.03.039
• Languages: English
• ISSNs: 0887-2333

Abstract

Abstract: At a joint workshop organized by RIVM and BfR, international experts from governmental institutes, regulatory agencies, industry, academia and animal welfare organizations discussed and provided recommendations for the development, validation and implementation of innovative 3R approaches in regulatory toxicology. In particular, an evolutionary improvement of our current approach of test method validation in the context of defined approaches or integrated testing strategies was discussed together with a revolutionary approach based on a comprehensive description of the physiological responses of the human body to chemical exposure and the subsequent definition of relevant and predictive in vitro, in chemico or in silico methods. A more comprehensive evaluation of biological relevance, scientific validity and regulatory purpose of new test methods and assessment strategies together with case studies that provide practical experience with new approaches were discussed as essential steps to build up the necessary confidence to facilitate regulatory acceptance. Highlights: Validation in the context of defined approaches or testing strategies was discussed. In a revolutionary approach, validation is knowledge-based, flexible, iterative. A thorough description of biological domain and toxicological effects is needed. Multi-stakeholder involvement is required in evaluation of new methodologies. Case studies are showcases to build confidence in new approaches and technologies.